Syed Mohammad Ali Kazmi

Author

The University of Texas Southwestern Medical Center ORCID

Also Known As

Muhammad Kazmi, Nilesh Verma, S A Kazmi, S Kazmi, S M A Kazmi, S. Kazmi, S.M.A. Kazmi, Syed A. Kazmi, Syed Ali Kazmi, Syed Ashoor Hasan Kazmi

188

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center The University of Texas MD Anderson Cancer Center Southwestern Medical Center Capital Health

About

Syed Mohammad Ali Kazmi is an author at The University of Texas Southwestern Medical Center specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	468
2	Health Sciences	2	2	291
3	Public Health	2	2	39
4	Cell Biology	1	1	45
5	Clinical Nutrition	1	1	16

Syed Mohammad Ali Kazmi

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment Maria Pia Morelli, Michael J. Overman, Arvind Dasari, Annals of Oncology OncologyHealth SciencesTumor HeterogeneityMedicineColorectal Cancer	2015	247
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits Denise Corti, Paolo Paoli, Maura Calvani, Oncotarget	2015	150
Autologous Hematopoietic Stem Cell Transplantation May Reverse Renal Failure in Patients with Multiple Myeloma Gaurav Parikh, Ali Imran Amjad, Rima M. Saliba, Biology of Blood and Marrow Transplantation	2009	80
Characteristics of Sweet Syndrome in Patients With Acute Myeloid Leukemia Syed Mohammad Ali Kazmi, Naveen Pemmaraju, Keyur P. Patel, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyMixed-phenotype Acute LeukemiaHematologyPathologySweet Syndrome	2014	67
Mortality from sudden unexpected death in epilepsy (<scp>SUDEP</scp>) in a cohort of adults with intellectual disability Reza Kiani, Freya Tyrer, Amala Jesu, Journal of Intellectual Disability Research	2013	60
Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells Nicholas Heaney, Francesca Pellicano, Bin Zhang, Blood	2010	57
Impact of Molecular Alterations and Targeted Therapy in Appendiceal Adenocarcinomas Kanwal Raghav, Aditya Shetty, Syed Mohammad Ali Kazmi, The Oncologist	2013	55
Weekly docetaxel, cisplatin, and 5‐fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer Michael J. Overman, Syed Mohammad Ali Kazmi, Jagriti Jhamb, Cancer	2010	52
VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment Yuqing Zhang, Huocong Huang, Morgan Coleman, JCI Insight Cancer ImmunosurveillanceAngiogenesisImmunologyTumor ImmunityVegf Expression	2021	45
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation Syed Mohammad Ali Kazmi, Maliha Nusrat, Hilal Gunaydin, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyTransplantationMarrow TransplantationMedicineStem Cell Transplantation	2015	44

Page 1